Press "Enter" to skip to content

DrugPatentWatch and Bloomberg: Are there too many generic patent challenges?

Listen to this article

Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing.

Why might this be a problem?

    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry
    ✓ 505(b)(2) & Biosimilars
    ✓ Insightful Articles & Case Studies
    ✓ Patent Litigation & Challenges

    First 30 days free

    ➤ Sign up
    Do NOT follow this link or you will be banned from the site!